{"name":"IntoCell, Inc","slug":"intocell-inc","ticker":"","exchange":"","domain":"","description":"IntoCell, Inc is a biotechnology company focused on developing innovative therapies. The company's lead candidate, ITC-6146RO, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFAzbHpHTGNTeVktUUtNamQ4S0lrYW40WVoxaXgyQkNXem9mWlNEVEFlQ2NvT3BOU0xiX0x6MHBGWDRBVU9XNXQ4UEhQSFdWR2huLU5lX0tvTGhGWG5yemF1TkRzZUdfaW5fdHFLVWRESzNQblVVdFFn?oc=5","date":"2025-11-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"IntoCell and Xcellon Biologics to advance ADC development - Pharmaceutical Technology","headline":"IntoCell and Xcellon Biologics to advance ADC development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxQN2NBQWZJXzBEcHppYjZaeUpWWVRWbkpHMk9lLUpRRElmd1d4RHBlQ0hZUnd6Ml94SElLMDBNUTRwdHRTTVdiQ3ZNakNTQ3JiMlhfbi1yNndVa21XbEpwNG5kWFRFVl9GNzNqWnlYOHBweXFhVVpxLS1aOTg0bmR6Y2pWSkJIMkZISG9DSTRTOEVGNTFSeDVkcmhsWXd6eUZOak40d2hsVHhleXlfdG5DQUpxb2JBQUJIeUZ0Um04bTVyTmFGeUtYZlYwUTEzeXNOUHVOZ1lWMmFHS3pBNkZmcHpBU3VnbDJTUGJuWmpOckFVVGh5Z0xQelhOa0tIWG9JUk51NHNoWGRQQXBuc3V2RXk4bw?oc=5","date":"2025-10-30","type":"deal","source":"PR Newswire","summary":"Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities - PR Newswire","headline":"Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Ca","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOY3J6ZEpPY2JzekQtUG8wSmxXSng5QV9WdnJrUXdpUUZBTE5LQXVXLTBoaFdZWnkycnlOUmdNSmIwaURyQzl6eDhEZHNaNEFEMnBrV1dOcnhKSUVXTHlKXzBsdlIyYjlIcjUxajQzR3doTkJOUmtBUUVROE9iUDNuR3VBZUt0MzZpRDJiRlJfUzNIcXY2MFVBT2dWZ0UxSXFYMy1RZWFENklyYXNKU0NJWmxMMXFLejhsM2VvRQ?oc=5","date":"2025-10-30","type":"deal","source":"Contract Pharma","summary":"Piramal Partners with IntoCell to Explore Opportunities in ADC Development - Contract Pharma","headline":"Piramal Partners with IntoCell to Explore Opportunities in ADC Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPVW53bW5HOEZHZGV4SHVxMXlpR2U4M3ZXUlZ3bzJHMnRqdlY5QTFJMVBtTm52LWZteENWd3hBZnoybWdNM0xZT3dBYTEycVNONWVkTTFobmpMc0RkWUZ6M1NhLXhHbWFUVmVKdEtaZnhzQk1uY1pub00zOFpybDc0UUlxNkJvdVV3T1E5VTlkSHFWUF94eFZheUpsN0lUSXVMcEI0b2xxa19qaEE3TUpWZGwyUG1tZXVDWmpRanlHZlI0RUxjQkFGMnJwRm5rQmJTLTF1Mnk1bW9CcTdGSHRQbkZVM2NYOEg4THYwT3U5ZmdBNExoWHc?oc=5","date":"2025-10-30","type":"deal","source":"BioSpectrum India","summary":"Piramal Pharma Solutions partners with IntoCell, expanding Payload-Linker Platform and Bioconjugate Capabilities - BioSpectrum India","headline":"Piramal Pharma Solutions partners with IntoCell, expanding Payload-Linker Platform and Bioconjugate Capabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQemx4Ul9LbHR5WHgzaThwcDlDRktKVFJySGROZUpUT01XNC1QOFo3WFVXY2ZBYXBYZFg1azJUX2ZhaVpObWUtRGRDdVhvVEc5RDhQZ2Rmdi1wY08tbDFZbkpiR2hJNFU1eG5hbDZ6RERFcE5MV21pcEx0a2dKS1o3atIBlAFBVV95cUxQanVjdlUtUHdpWFlhUE1pZmdfMDdnX1VOenF5UEFVb2dlaHktNUZXT1A2bGUxcnZZcUdPRnFPQlVUS1cxQWgwQWJlY0U1NVNEQTZWOUVyeVdqM0JVRkZuSlZ1RFpHZWhHTDBoVHhQZmxUcEdMeHpFdGFXcVo1NXA2QjFQd2JPMEV1VjJBME1lZHFVQlZq?oc=5","date":"2025-07-03","type":"deal","source":"Chosunbiz","summary":"Big Pharma partnerships boost biotech IPO expectations in South Korea's KOSDAQ - CHOSUNBIZ - Chosunbiz","headline":"Big Pharma partnerships boost biotech IPO expectations in South Korea's KOSDAQ - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9yU0xjS3JWNzNueWlYaEtHQzJRNHRHN3NVblFkd01YVU5LWlpOZ3h6QmNrTmFMV0dPLUNnQ291dkZpVlVWeU9hSEJzRXkzb3RXaHYxajdDeFd5NG5RVGhFb0lGWXdfZEpJb3h0UTVn0gFyQVVfeXFMT3NEallnZEdfTkhKalhGUXpuVzF4UlBKM1VpSm1ZeE1FclJrUGExc2ltUWtoRUZUN0dBSVVHM293ck9kanlFNFBlLWJzTHdJOUNUcmJYUE02MEhXZDhoSUlxcE5pRmVqbmRaY0s4WU1IODRn?oc=5","date":"2025-04-28","type":"deal","source":"koreabiomed.com","summary":"IntoCell eyes 10 licensing deals by 2028 with Kosdaq IPO on deck - koreabiomed.com","headline":"IntoCell eyes 10 licensing deals by 2028 with Kosdaq IPO on deck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5nN0UwZFN6SS00YWR3UUd6SkxjRHJTdjJqUi1XdmhLbS1CMmlkckFmWjFTRmhkQXRBWVBOdkpyVHowd1Zxem1QbVU5czBRLUNnTVZIMGFhVlRZa0pVY2ZJQlVhWEh2bGk1ZjBXNERFNEpveF94LWlz0gF8QVVfeXFMT0p4dzQ4bXFoMlhaLTBIMFJzVFhpS3FhQmpBX29fSThZZk9hT2hWSlZ2X2xJSDNsTjhZRXJ3bUF3Uk52NWhvUWlhbmVkRGdKTEJnSnJLdUdPY3V3R3FXMXNmbk1UM253d0k4TEN0X2lfb2VfbjJuYzJaZjFVNA?oc=5","date":"2024-08-18","type":"pipeline","source":"BioInformant","summary":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment? - BioInformant","headline":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQRnN6cDVBZC1YZXlHOTFzLVlVTkQ5ZjV2cEdGYU5uaEhOSDJUTTg2c2ZZTlk0SUI1bFFaT2RaQnM2a2J0ZmhRaktwbUJWZkhGdFB0N0RDZWQyREpMRTUyZ2FvdERGZExacHZGZnI0Y3ZmNmJLVWRRRWFfZ081dWJOd3BNQWhPV1plQlpiMDBKeG9yTjVoaUhuQmpLTWVKeEdOWmpaTjU4Z2g2S1ZQYkFWTW95dEdtSGJoNVc2VHY3c1JYX00?oc=5","date":"2024-04-29","type":"pipeline","source":"Healthcare Brew","summary":"Walgreens rebrands specialty pharmacy unit, gets into cell and gene therapy - Healthcare Brew","headline":"Walgreens rebrands specialty pharmacy unit, gets into cell and gene therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVnE1Q0VZN0Y5X19qMVV4VVRQbVRtYURpaGhkTkZWOHMxSHlCWWhwTFM5OU50WEVYXy1lQ3h1MDNVMTZJUHp3LUZRMjYzMF9DdWpNejc0ejJJek5uX0ZlZF9sOG9TNk9LTjFMSjdXaGdFdmRSTno1R1FXUkI5Qm54YTM4NFo1eHN1VFpjNkc4eWZVam9RdVRRa0xZOWpaQUh5NXBKaG0tN1p2N3hiZkgxN1BvTkQ?oc=5","date":"2024-01-05","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Biotech investment diversifies into cell therapies and immunology - drugdiscoverytrends.com","headline":"Biotech investment diversifies into cell therapies and immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOR2cwYjNIR2N0R2tWTUt1TXBTTUNiMHRVT0pHXzNLUHk3eVNlemN5OHdPX2trTVY2OThwYzltd3ZsZDFpeGZQUE9od3ExekdzYzNxcWdZQVBrMDk4aUs1S01OTlMxWTNRV3M1T01McHpVUkdFenotTTdjc2U4S2NoM1lieThMWVZOaVhZcTVadTgxT2hTejRiQ1ln?oc=5","date":"2023-08-24","type":"pipeline","source":"BioPharma Dive","summary":"Startup Cellares adds $255M as investors pour cash into cell therapy production - BioPharma Dive","headline":"Startup Cellares adds $255M as investors pour cash into cell therapy production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQS3lvbXBEY0o1MVk0Z1VsbWF3bHZTeGNCT3RpN0RJWGl6TWVQVDMyTllGTVAzNmRMNzB2djE5UHZiaW1qTVNLVDZKcUhFaVRpQUpXWi10c1BQb3NaRUNLUTl6cTJEQVBjd3ZjakcwaE5ZTjV1ZVRFWXZ0TENKc2VkaEw4SUc1cy1qWmJpbzlac21jaVAyZzg2QTE1bTJwUTBveGVFdnExdlBrcG5VbjNz?oc=5","date":"2023-06-04","type":"pipeline","source":"C&EN","summary":"Siegfried marks its 150th anniversary with a foray into cell and gene therapy - C&EN","headline":"Siegfried marks its 150th anniversary with a foray into cell and gene therapy - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQYjhpck9lZ1lORGNxSDFRbUl1TGpGbTNJOEVobXk3bkt4emtKSjZJd2NZRGNCQ2wzbVZaOUx1Nk5tcDRQNFRJOVh0S2RwQ1d2Y21pMkZ3YmZXTFo4LVFGVmJvYnpOWGJPZXpmWmthd3VhNHQ0SUZvNjlXMFdIUzRSVENGT29rUVlhRzNVVk43dnhLdThRbG9XVV9BNUR5VnFRVGV1X1FiT3p6UURPczlOV1dxNDNFUXYtSmo5ek8tUGxlTE0?oc=5","date":"2021-08-05","type":"pipeline","source":"Fierce Pharma","summary":"Boehringer Ingelheim packs new tech into cell-culture plant set for October start - Fierce Pharma","headline":"Boehringer Ingelheim packs new tech into cell-culture plant set for October start","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}